InsidersTradesSigma
AlzeCure Pharma AB: directors' dealings · Finland · FIN-FSA
FI:alzecure-pharma-ab-09de39SE0025399124FI·FIN-FSAMcap 160M€Healthcare
Explore the full management transaction log of AlzeCure Pharma AB, a listed equity based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, AlzeCure Pharma AB has recorded 2 insider filings. Market capitalisation: €160.3m. The latest transaction was filed on 26 August 2025 (Purchase). Among the most active insiders: Martin Jönsson. The full history is free.
2
Insider Decl.
0
Thresholds
€31,030
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.40 €
Analyst consensus
1 analystsStrong buy
5.00 €Target 5.00 €(+258%)5.00 €
Income statement
Net income−47.7 M€0.0% margin
Valuation
P/Book4.9x
Beta-0.04
Balance sheet & cash
Market cap160.3 M€
Total debt2.6 M€
Free Cash Flow−34.6 M€
Debt / Equity20%
Profitability & ownership
ROE-433.8%
ROA-113.7%
% insiders42.9%
% institutions9.1%
Last declaration on 26 August 2025
Declarations2 total
Executives●Purchase35FIN-FSA
€1,5858,067 shares@ €0.19650.0010% mcap100.0% of flow
Aktie
FI:A003R766-1·
Ideal exit: 22 May 2026 (T+270)
Executives●Purchase23FIN-FSA
€29,445150,000 shares@ €0.19630.018% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003R169-1·
Ideal exit: 20 Apr 2026 (T+270)
2 of 2 declarations